Craft

Nuvectra

Stock Price

$0.4

2021-01-28

Market Capitalization

$67.6 M

2020-03-17

Revenue

$48.8 M

FY, 2018

Nuvectra Summary

Company Summary

Overview
Nuvectra is a neuromodulation medical device company focused on the development and commercialization of a neurostimulation technology platform used for the treatment of various disorders through stimulation of tissues associated with the nervous system. The company's neurostimulation technology platform has the capability to provide treatment to patients in several established neurostimulation markets, including spinal cord stimulation, sacral nerve stimulation, and deep brain stimulation. The company also offers Nuvectra's Algovita SCS system, or Algovita, that is used for the treatment of chronic pain of the trunk and limbs.
Type
Public
Status
Closed
Founded
2016
HQ
Plano, TX, US | view all locations
Cybersecurity rating
Sectors

Operating MetricsView all

Trademarks

5

FY, 2016

Trademarks (Foreign)

17

FY, 2016

Trademarks Pending

31

FY, 2016

LocationsView all

1 location detected

  • Plano, TX HQ

    United States

    5830 Granite Pkwy #1100

Nuvectra Financials

Summary Financials

Revenue (Q2, 2019)
$12.3M
Gross profit (Q2, 2019)
$6.8M
Net income (Q2, 2019)
($11.1M)
Cash (Q2, 2019)
$69.8M
EBIT (Q2, 2019)
($10.2M)
Enterprise value
$42.5M

Footer menu